Curaleaf Laboratories are the UK-leading experts in the manufacture and distribution of EU-GMP medical cannabis as part of Curaleaf International, a subsidiary of Curaleaf Holdings, Inc. the largest cannabis company in the world.
With over a decade of experience in unlicensed medicines (Specials), Curaleaf have invested heavily in our state-of-the-art UK manufacturing facility, making us perfectly positioned with our international vertically integrated supply chain to deliver cannabis-based medicinal products (CBPM’s) of the highest quality for specialists to prescribe to their patients.
In 2019, Rokshaw joined the Curaleaf International group and because of this, in August 2020, became the first manufacturer of full spectrum medical cannabis in the UK. We aligned with the Curaleaf mission, to provide wider access and unlock the potential of medical cannabis to those who need it.
Curaleaf’s wealth of medical cannabis experience, combined with a network of supply and distribution partnerships throughout Europe and the UK, mean that it is uniquely positioned to meet the rapidly growing demand for cost-effective, consistent, premium quality medical cannabis products in the UK.
We empower patients and healthcare professionals to unlock the transformative power of medical cannabis.
As leaders in medical cannabis research, you can feel confident you will always receive safe, high-quality care.
We specialise in the supply of EU GMP medical cannabis, making it more affordable than ever before!
